Two Receptors, Two Isoforms, Two Cancers: Comprehensive Analysis of KIT and TrkA Expression in Neuroblastoma and Acute Myeloid Leukemia release_p4mdfby6d5hbnj2vtvhlsgedlq

by Timofey D. Lebedev, Elmira R. Vagapova, Vladimir I. Popenko, Olga G. Leonova, Pavel V. Spirin, Vladimir S. Prassolov

Published in Frontiers in Oncology by Frontiers Media SA.

2019   Volume 9, p1046

Abstract

Pediatric cancers represent a wide variety of different tumors, though they have unique features that distinguish them from adult cancers. Receptor tyrosine kinases KIT and TrkA functions in AML and NB, respectively, are well-characterized. Though expression of these receptors is found in both tumors, little is known about KIT function in NB and TrkA in AML. By combining gene enrichment analysis with multidimensional scaling we showed that pediatric AMLs with t(8;21) or inv16 and high KIT expression levels stand out from other AML subtypes as they share prominent transcriptomic features exclusively with KIT-overexpressing NBs. We showed that AML cell lines had a predominant expression of an alternative TrkAIII isoform, which reportedly has oncogenic features, while NB cell lines had dominating TrkAI-II isoforms. NB cells, on the other hand, had an abnormal ratio of KIT isoforms as opposed to AML cells. Both SCF and NGF exerted protective action against doxorubicin and cytarabine for t(8;21) AML and NB cells. We identified several gene sets both unique and common for pediatric AML and NB, and this expression is associated with KIT or TrkA levels. NMU, DUSP4, RET, SUSD5, NOS1, and GABRA5 genes are differentially expressed in NBs with high KIT expression and are associated with poor survival in NB. We identified HOXA10, BAG3, and MARCKS genes that are connected with TrkA expression and are marker genes of poor outcome in AML. We also report that SLC18A2, PLXNC1, and MRPL33 gene expression is associated with TrkA or KIT expression levels in both AML and NB, and these genes have a prognostic value for both cancers. Thus, we have provided a comprehensive characterization of TrkA and KIT expression along with the oncogenic signatures of these genes across two pediatric tumors.
In text/plain format

Archived Files and Locations

application/pdf  4.2 MB
file_xhh6ub4x7rhdtncdp2xfcs3ufa
web.archive.org (webarchive)
pdfs.semanticscholar.org (aggregator)
fjfsdata01prod.blob.core.windows.net (publisher)
web.archive.org (webarchive)

Web Captures

https://www.frontiersin.org/articles/10.3389/fonc.2019.01046/full
2020-02-16 06:40:52 | 39 resources
webcapture_do7spv3gvzbihfxzbjvnbtpj5m
web.archive.org (webarchive)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Date   2019-10-18
Language   en ?
Container Metadata
Open Access Publication
In DOAJ
In ISSN ROAD
In Keepers Registry
ISSN-L:  2234-943X
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: 156ad583-bc73-46e3-8136-4630ec020070
API URL: JSON